학술논문

First-in-human, multicenter, phase i dose-escalation and expansion study of anti-mesothelin antibody-drug conjugate anetumab ravtansine in advanced or metastatic solid tumors
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 1 June 2020, 38(16):1824-1835)
Subject
Language
English
ISSN
15277755
0732183X